Rory Chan

Academic, Clinical Senior Lecturer (Teaching and Research)/Hon Consultant

University of Dundee

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Rory Chan is a Clinical Senior Lecturer (Teaching and Research) and Honorary Consultant at the University of Dundee, UK. His research focuses on respiratory medicine, particularly the efficacy of treatments for asthma and chronic obstructive pulmonary disease (COPD). Recent publications include studies on the impact of biological therapies such as dupilumab and mepolizumab, as well as advancements in precision medicine related to type 2 cytokines and asthma management.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Collaborators (3)

Brian J. Lipworth

UNITED KINGDOM

View details

Remo Poto

Università degli Studi di Napoli Federico II

ITALY

View details

Zuzana Diamant

Guest Professor

Catholic University of Leuven

BELGIUM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Rory Chan

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Body mass index and lung function decline in persistent asthma

Characterizing the preserved ratio impaired spirometry phenotype in all severities of asthma

Efficacy of dupilumab and mepolizumab in eosinophilic COPD: insights from phase 3 trials

Impact of dupilumab on oscillometry and spirometry derived ratios in severe refractory asthma

Real‐Life Indirect Case Matched Comparison of Dupilumab and Tezepelumab on Airway Oscillometry

Bronchodilator Reversibility of Spirometry and Oscillometry Ratios in Severe Refractory Asthma

Type 2 biomarkers and airway hyper-responsiveness disconnect in patients with uncontrolled severe asthma taking benralizumab or dupilumab

Real-life evaluation of novel forced expiratory ratios with asthma exacerbations and symptoms

Advancing precision medicine for asthma by focusing on type 2 cytokines and alarmins

An update on oscillometry in asthma

Collaborators (3)

Brian J. Lipworth

Remo Poto

Zuzana Diamant

Make your next move.